{"id":"W2999136960","doi":"10.1016/j.annonc.2019.10.022","title":"Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"PharmaMar; Direction Générale de l’offre de Soins; Institut National Du Cancer; Chugai Pharmaceutical; Roche; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Novartis; Amgen; Pfizer; CNIB; AbbVie; Merck","keywords":"Vemurafenib; Medicine; Internal medicine; Oncology; Cohort; Lung cancer; Trametinib; Dabrafenib; Cancer; Metastatic melanoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005364755,0.0001009996,0.0001851559,0.00003272113,0.00002399087,0.000004197692,0.00009192018,0.0001204457,0.00002199024],"category_scores_gemma":[0.00002251278,0.00009003501,0.00002582331,0.00008409018,0.00006339547,0.000003908327,0.00006288952,0.00007181498,0.000001813028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004499764,"about_ca_system_score_gemma":0.0001354584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00010754,"about_ca_topic_score_gemma":0.0002658488,"domain_scores_codex":[0.9993225,0.00004124266,0.0001739817,0.0002332313,0.00005517521,0.0001738798],"domain_scores_gemma":[0.9995946,0.0000177531,0.0000993842,0.00009700872,0.00009866053,0.00009258796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009729092,0.0008282957,0.7130746,0.0003106931,0.000170735,0.00003893602,0.002076158,0.0003764873,0.2487766,0.0001307873,0.007997088,0.0252467],"study_design_scores_gemma":[0.007793393,0.01024978,0.6170927,0.0000584023,0.00007721585,0.000005007438,0.0002600707,0.000348824,0.3257082,0.00005989285,0.03778962,0.0005568315],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963554,0.0003637909,0.00007915616,0.001096554,0.00004733663,0.0002235622,0.00004771837,0.000003663249,0.001782776],"genre_scores_gemma":[0.9975799,0.0001882947,0.0003019133,0.001657367,0.00006949099,0.00003193138,0.00009365885,0.0000126831,0.0000647427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0959819,"threshold_uncertainty_score":0.3671521,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02275642131417564,"score_gpt":0.2925721636425658,"score_spread":0.2698157423283902,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}